praxis-text-mobile

News

The Perils of Impatience and the Risk of Rapid Research

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

You may be aware of the much discussed retraction last week of the #Lancet article which claimed that hydroxychloroquine was associated with increased in-hospital mortality and ventricular arrhythmia when used to treat #Covid19.

The harms caused by this publication are many. Importantly, it causes the public to question their faith in #medicine, #research and #clinicaltrials and damages the case for the use of #AI and #RWD in #clinicaltrials. Critical right now, as we turn to research to answer the questions about tackling this pandemic.

The failures are at many levels, including the #peerreview process. In this #Nature briefing, our PRAXIS Australia Ltd Director, Ian Kerridge, and Macquarie Uni Bioethicist, Wendy Rogers, discuss some of the critical and ongoing impacts of this paper.

#researchfraud #integrity #clinicaltrials #realworlddata #peerreview#hydroxychloroquine #lancetgate

Link to full article: https://idp.nature.com/authorize?response_type=cookie&client_id=grover&redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-020-01695-w

Sign-up to our Mailing List to receive our latest news and updates